MARY DENIUS: Open Payments
NPI 1427349273 · POPLARVILLE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,487 in 121 payments from 34 companies in 2025. Trend: 2023 $2,688 · 2024 $3,223 · 2025 $2,487
Food & beverage: $2,388Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $364 |
| Merck Sharp & Dohme LLC | 12 | $245 |
| Novartis Pharmaceuticals Corporation | 14 | $239 |
| Daiichi Sankyo Inc. | 11 | $195 |
| Gilead Sciences, Inc. | 4 | $103 |
| E.R. Squibb & Sons, L.L.C. | 5 | $86 |
| PFIZER INC. | 6 | $83 |
| TerSera Therapeutics LLC | 3 | $80 |
| AstraZeneca Pharmaceuticals LP | 4 | $77 |
| PharmaEssentia USA Corporation | 3 | $74 |
Products named: KEYTRUDA, Enhertu, Trodelvy, DARZALEX, TECVAYLI, OPDIVO, KISQALI, BESREMI.
Industry payments across MS — which companies pay providers there.
